The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.
about
IL-6 Plays a Crucial Role in HBV InfectionTherapeutic strategies for the clinical blockade of IL-6/gp130 signalingProtein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cellsDifferential expression of liver interleukin-6 receptor-alpha in female versus male ethanol-consuming ratsSoluble ST2 blocks interleukin-33 signaling in allergic airway inflammationSoluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responsesContribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritisAbrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage displayIFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infectionHigher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans.Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome.The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of AtherosclerosisCoexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infectionThe therapeutic potential of interleukin-6 hyperagonists and antagonists.The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cyclingConverting IL-15 to a superagonist by binding to soluble IL-15R{alpha}IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosisThe roles of interleukin-6 in the pathogenesis of rheumatoid arthritis.Human cancer growth and therapy in immunodeficient mouse models.The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysisInterleukin-6 trans-signalling in chronic inflammation and cancer.Novel genetically-humanized mouse model established to evaluate efficacy of therapeutic agents to human interleukin-6 receptor.Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery.Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.sIL-6R: more than an agonist?Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo.IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranesSoluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses.Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha.Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?Amigo2-upregulation in Tumour Cells Facilitates Their Attachment to Liver Endothelial Cells Resulting in Liver Metastases.The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphomaHitting a complex target: an update on interleukin-6 trans-signalling.IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.The effect of physical activity on mediators of inflammation.Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.
P2860
Q26774879-A3DB23FE-9F8A-490C-9157-530AA8C37A09Q27002391-0CCE6034-8035-4090-A061-26D37D3460C9Q28345234-890EFEB2-A623-404D-9B73-DBA162B74A2FQ28578815-D0BFDA27-CF46-414C-B6C7-6EB59F612D3EQ28586791-7DDDD4F3-842D-4CC7-953B-4115FC5DD8EDQ28634282-75AF7593-A823-4CE9-9C03-64F1C35BD4A2Q30318502-798C9046-50B7-4629-963D-FCA928948151Q30434426-D4574E43-1D0E-4CC1-AFA1-B9F5C827B881Q33254113-63BF6655-5EA7-440F-8091-C5414077309AQ33586624-F1730C01-AFF3-48C0-B917-21A8080DDEBCQ33654592-D1484AF6-04F6-4AEF-8A10-8E31D7B8C122Q33750620-4CDE656F-1049-48E3-92C9-708BEEF79FBFQ33838927-34FA01C2-280C-401A-BC13-C58358B7F3C9Q33889571-1F514887-C661-4252-BC6B-2623FD1F79D5Q34096100-B48F8567-A259-4D2E-BD16-34E645D8B78BQ34426479-018691B2-9D8D-4B02-AEB5-512FFBF881B6Q34430168-94A267E8-65E6-4DBD-8C69-81E5660995A5Q34505786-40331040-310B-4C49-9C0E-0CA9F3598295Q34694913-96405E94-E2FB-4F3D-A56B-4C2D3E45194AQ34955491-4AB8C4D5-3898-43B9-A104-2C33A1AEEC90Q35429154-C1E7D75F-75DC-4A1D-98A7-2C2689741FCDQ35545282-36302D0C-F0D8-485F-9049-3F734C9A6FD4Q35810127-BDA51AD4-6EAB-4939-B11F-735D24AAFBA8Q35864053-E3C10BD6-E216-45C1-A928-4EB0C490F95AQ36460931-23522DA2-A057-45F6-BF40-FEB961CF2BE7Q36579862-A65F108B-A4A1-4F8C-9282-8B569B541641Q36738527-E825F7AD-D307-46D3-A6D9-A1A2DA2C7A1CQ36835490-F2F8A45A-8407-4652-8ACE-8B0D4D024871Q36921227-E7FD9F3A-0513-4130-9121-62E2737001FEQ37163250-CBD8395E-1CCC-43A1-A0ED-797C67B4D674Q37238620-C28F0B9C-96EA-4A01-85C1-6B188D27A2C0Q37252579-F4B09F40-DEBC-4F1B-B800-E4FE6A0B5DE5Q37375605-2A1D8081-0C9F-4F00-A7E7-502AF36F03FDQ37453953-FB3A3238-DD1C-4A87-A147-6104B6B35D1CQ37685867-77A6E5DE-2A31-4F26-ABCA-DF358F6F85EDQ37733947-50BB5D05-163E-4F6E-87EC-08716FB2D96BQ37983123-C660D633-18BB-49B3-ADAB-BB0182E39D91Q38058509-90D4F4A3-556C-4C7B-B2C8-0C12EEAAABD4Q38134104-BA824A48-139F-47D8-B582-37F830247189Q38183314-2ED268EF-BCC2-4821-965C-7A92E8CAAD04
P2860
The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The function of the soluble in ...... the plasma half-life of IL-6.
@ast
The function of the soluble in ...... the plasma half-life of IL-6.
@en
type
label
The function of the soluble in ...... the plasma half-life of IL-6.
@ast
The function of the soluble in ...... the plasma half-life of IL-6.
@en
prefLabel
The function of the soluble in ...... the plasma half-life of IL-6.
@ast
The function of the soluble in ...... the plasma half-life of IL-6.
@en
P2093
P2860
P356
P1476
The function of the soluble in ...... the plasma half-life of IL-6.
@en
P2093
Müllberg J
Rose-John S
P2860
P304
P356
10.1084/JEM.183.4.1399
P407
P577
1996-04-01T00:00:00Z